Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David James Lennon currently holds 518,622 shares of Aadi Bioscience, Inc. (AADI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David James Lennon has been a net seller of AADI stock. They have purchased $0 and sold $1.1M worth of shares.
David James Lennon's most recent insider trade was on Apr 9, 2026, when they sold 14,500 shares at $3.38 per share.
David James Lennon serves as Executive at Aadi Bioscience, Inc. (AADI). They have executed 15 insider transactions totaling $1.1M over their tenure at the company.
David James Lennon holds the position of Executive at Aadi Bioscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
David James Lennon has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David James Lennon was on Apr 6, 2026, when they sold $359.4K worth of WHWK shares. This transaction involved 102,395 shares at $3.51 per share.
David James Lennon currently owns 518,622 shares of Aadi Bioscience, Inc. (AADI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David James Lennon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David James Lennon has 15 Form 4 filings on record as an insider at Aadi Bioscience, Inc..
Set alerts for David James Lennon and 40,000+ other insiders.